Document is current
Any future updates will be listed below
-
Authors
Nakagawa, Takuya https://orcid.org/0000-0003-1216-4822
Luebeck, Jens https://orcid.org/0000-0003-4391-979X
Zhu, Kaiyuan
Lange, Joshua T.
Sasik, Roman https://orcid.org/0000-0002-9266-8993
Phillips, Chad
Sadat, Sayed
Javadzadeh, Sara
Yang, Qian
Monther, Abdula
Fassardi, Santiago
Wang, Allen https://orcid.org/0000-0001-9870-7888
Pestonjamasp, Kersi
Rosenthal, Brin
Fisch, Kathleen M. https://orcid.org/0000-0002-0117-7444
Mischel, Paul https://orcid.org/0000-0002-4560-2211
Bafna, Vineet https://orcid.org/0000-0002-5810-6241
Califano, Joseph A. https://orcid.org/0000-0002-4715-6761
-
Funding
Funding for this research was provided by:
Support from the Gleiberman Head and Neck Cancer Center
Japan Society for the Promotion of Science Overseas Research Fellowship
- License Information
-
More Information
Article History
Received: 22 July 2024
Accepted: 22 February 2025
First Online: 26 March 2025
Competing interests
: P.M. is a co-founder, chairs the scientific advisory board (SAB) of, and has equity interest in Boundless Bio Inc. (BBI). P.M. is also an advisor with equity for Asteroid Therapeutics and is an advisor to Sage Therapeutics. V.B. is a co-founder, consultant, SAB member and has equity interest in Boundless Bio and Abterra. J.T.L. is an employee of BBI. J.L. previously consulted for BBI. The other authors have no competing interests to disclose.
